Clinical trials in Heraklion – page 18

244 clinical trials in Heraklion, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Heraklion at a glance

244

clinical trials

Research sites1

Quick filters

244 trials in Heraklion

Open in trial search

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Bi 1015550
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Study of Fulvestrant and Abemaciclib for Women with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Eli Lilly & Co.

Contact Research Centre

Study to Compare Fianlimab and Cemiplimab Combination with Cemiplimab Alone for Adults with Advanced Non-Small Cell Lung Cancer

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Cemiplimab
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Study on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Fipaxalparant
Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Contact Research Centre

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Selpercatinib
Sponsor:Eli Lilly & Co.

Contact Research Centre

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Brodalumab
Sponsor:Leo Pharma A/S

Contact Research Centre

Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Everolimus
Sponsor:Genentech Inc.

Contact Research Centre

Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Amlodipine
Sponsor:Win Medica Pharmaceutical S.A.

Contact Research Centre

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Registered drugNo placebo

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anhydrous Cidofovir
Sponsor:AiCuris Anti-infective Cures AG

Contact Research Centre

Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8
Sponsor:Eli Lilly & Co.

Contact Research Centre

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Heraklion

What the registry says about research in the country

01 Autoimmune Conditions

Groundbreaking research focusing on systemic lupus erythematosus and cutaneous lupus, evaluating novel therapeutic approaches. Studies aim to assess treatment effectiveness and long-term safety profiles.

Lupus (SLE and CLE)
Psoriatic Arthritis
Hidradenitis Suppurativa

Multiple trials exploring innovative medications for chronic autoimmune conditions.

02 Gastrointestinal Disorders

Comprehensive studies investigating treatments for inflammatory bowel diseases, including trials for both mild and severe cases. Research focuses on combination therapies and long-term management strategies.

Crohn's Disease
Ulcerative Colitis
Intra-abdominal Infections

Advanced therapeutic approaches for chronic digestive conditions.

03 Oncology Research

Innovative trials targeting various forms of lung cancer and breast cancer, with a focus on advanced and metastatic disease states. Studies evaluate new combination therapies and treatment approaches.

Metastatic Breast Cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer

Exploring breakthrough treatments in cancer care.

Back to Greece All countries

Clinical trials in Heraklion – page 18

244 trials in Heraklion

Idiopathic pulmonary fibrosis

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Breast cancer

Study of Fulvestrant and Abemaciclib for Women with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer

Non-small cell lung cancer

Study to Compare Fianlimab and Cemiplimab Combination with Cemiplimab Alone for Adults with Advanced Non-Small Cell Lung Cancer

Idiopathic pulmonary fibrosis

Study on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis

Non-small cell lung cancer

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Psoriasis

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Breast cancer+3

Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Hypertension

Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

Herpes simplex

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Hidradenitis

Study of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa

Crohn's disease

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Filter the trials

Other cities in Greece

Clinical research in Heraklion

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Heraklion – page 18

244 trials in Heraklion

Breast cancer+3

Other cities in Greece

Related

Clinical research in Heraklion

Prefer not to search? Our Concierge searches the trials for you.